Metformin is a first-line medication for PMOS in women with insulin resistance, pre-diabetes, or who are trying to conceive. The standard adult dose is 1,500 to 2,000mg per day, usually 500mg three times with meals for the immediate-release formulation, or 1,000 to 2,000mg once daily for extended-release. Metformin lowers fasting insulin by around 30 percent, improves ovulation rates by 1.4 times, and reduces miscarriage rates by around 40 percent in PMOS. The 2023 International PCOS Guideline (still the standard of care under the new PMOS name from 12 May 2026) gave metformin a positive recommendation for PMOS specifically when insulin resistance, BMI elevation, or fertility goals are present. Metformin is not weight-loss medication; weight changes are modest (1 to 3 kg over 6 months) and come from improved insulin signaling, not direct fat burn.
Why metformin is used for PMOS
Metformin is the most-prescribed insulin sensitizer worldwide. It activates an enzyme called AMP-activated protein kinase (AMPK), which lowers liver glucose production, increases insulin sensitivity in muscle and fat tissue, and modestly suppresses appetite. Around 70 percent of women with PMOS have insulin resistance, and metformin directly addresses that mechanism.
The 2023 International PCOS Guideline recommends metformin in PMOS for:
- Insulin resistance or pre-diabetes (HbA1c above 5.7 percent, fasting glucose above 5.6 mmol/L, or HOMA-IR above 2.0).
- BMI elevation above 25 when lifestyle changes alone have not produced response over 6 months.
- Fertility planning, particularly for women with anovulation.
- Gestational diabetes prevention in women with PMOS and pre-pregnancy insulin resistance.
- Adolescent PMOS with severe insulin resistance, after at least 3 years post-menarche.
What metformin does for PMOS, with numbers
| Outcome | Average effect on metformin | Timeframe | Source |
|---|---|---|---|
| Fasting insulin | Reduced 30% | 12 weeks | 2022 Cochrane review (38 trials, 4,366 women) |
| HOMA-IR | Reduced 25-35% | 12 weeks | Same review |
| Ovulation rate | Increased 1.4x | 3-6 months | Same review |
| Live birth rate (fertility) | Increased 1.5x (vs placebo) | 12+ months | 2023 BMJ meta-analysis |
| Miscarriage rate | Reduced ~40% | First trimester | 2020 Lancet meta-analysis |
| Body weight | Reduced 1-3 kg | 6 months | 2022 Cochrane review |
| Free testosterone | Reduced 11% | 6 months | Same review |
| HbA1c (in pre-diabetes) | Reduced 0.3-0.5% | 6 months | Diabetes Prevention Program data |
The typical metformin dose for PMOS
Immediate-release (IR) metformin
- Week 1: 500mg once daily with the largest meal.
- Week 2: 500mg twice daily with meals.
- Week 3 to 4: 500mg three times daily with meals (1,500mg total).
- Long-term: 1,500 to 2,000mg total per day, split across meals.
The slow titration is the key to tolerating metformin. Jumping straight to 1,500mg/day causes the GI side effects that lead 20 to 30 percent of women to quit the medication.
Extended-release (ER) metformin
- Week 1 to 2: 500mg once daily with the evening meal.
- Week 3 onwards: 1,000 to 2,000mg once daily with the evening meal.
ER metformin has around half the GI side-effect rate of IR. Many doctors start women with PMOS on ER specifically for this reason.
Side effects of metformin in PMOS
| Side effect | Frequency | How to manage |
|---|---|---|
| Diarrhoea | 20-30% on IR, 10-15% on ER | Slow titration, switch to ER, take with food, ask about adding magnesium |
| Nausea | 15-20% | Take in the middle of meals, not before |
| Metallic taste | 10-15% | Usually resolves at 4-6 weeks |
| Bloating and gas | 15-20% | Usually resolves at 4-6 weeks, slow titration helps |
| B12 deficiency (long-term) | 5-15% over 5+ years | Annual B12 check, supplement 500-1,000 mcg/day if low |
| Lactic acidosis (rare) | Under 1 in 30,000 patient years | Stop if kidney function declines, illness with dehydration, or upcoming contrast imaging |
Metformin and weight loss in PMOS
Metformin causes a modest 1 to 3 kg weight loss on average over 6 months, mostly through appetite suppression and improved insulin signaling. It is not a weight loss drug. The dietary protocol matters far more. Women who pair metformin with a 30/30/40 PMOS diet lose roughly 2 to 3 times more weight than those who only take metformin, per multiple PCOS clinical trials.
The realistic expectation: metformin removes a metabolic barrier to weight loss, but the calorie deficit and the macro split do the actual work.
Metformin and fertility in PMOS
Metformin improves ovulation rates by around 1.4x and increases live birth rates by around 1.5x compared to placebo in women with PMOS undergoing fertility treatment. For women with PMOS trying to conceive without IVF:
- Metformin alone: ovulation rate around 50 percent vs 25 percent on placebo.
- Letrozole alone: ovulation rate around 60-70 percent.
- Metformin plus letrozole: roughly similar to letrozole alone for live births, but the combination may reduce miscarriage rates and gestational diabetes risk.
The 2023 International PCOS Guideline recommended letrozole as the first-line ovulation induction for PMOS, with metformin as an adjunct for women with insulin resistance or BMI above 30.
Metformin in pregnancy with PMOS
Metformin is considered safe in pregnancy (Pregnancy Category B). It crosses the placenta. The 2020 Lancet meta-analysis of more than 1,500 PCOS pregnancies on metformin found:
- Around 40 percent reduction in early miscarriage rate.
- Around 25 percent reduction in gestational diabetes incidence.
- No increase in birth defect rates compared to non-metformin pregnancies.
The decision to continue metformin into pregnancy is individualised. Some endocrinologists continue through the first trimester to reduce miscarriage risk, then stop. Others continue throughout pregnancy in women with insulin resistance.
Metformin vs inositol for PMOS
| Comparison | Metformin | Inositol |
|---|---|---|
| Mechanism | AMPK activation, reduces liver glucose | Improves insulin signaling at the cellular level |
| Prescription needed? | Yes | No (supplement) |
| Effect on fasting insulin | 30% reduction | 25% reduction |
| Effect on ovulation | 1.4x placebo | 1.5x placebo |
| Side effects | GI side effects 20-30% | Generally mild GI at higher doses |
| Cost (US, monthly) | $4-15 generic | $25-40 |
| Pregnancy use | Category B, often continued | Generally regarded as safe but less evidence |
| Best for | Insulin resistance, pre-diabetes, BMI above 30 | Mild to moderate IR, those who prefer non-prescription, fertility prep |
Read the deeper comparison in inositol vs metformin for PMOS.
How long should you stay on metformin for PMOS?
Metformin is a long-term medication, not a short course. Most women with PMOS who start metformin for insulin resistance, fertility, or weight management stay on it for years. The benefit reverses if the medication stops and insulin sensitivity returns to baseline within 4 to 8 weeks.
Reasons to stop or switch:
- Persistent GI side effects despite slow titration and switching to ER.
- Kidney function decline (eGFR below 30).
- B12 deficiency that does not respond to supplementation.
- Pregnancy (decision is individualised with obstetrician).
- Significant improvement of underlying insulin resistance via sustained lifestyle changes (rare but possible after 12+ months of consistent diet and exercise).
What to ask your doctor about metformin for PMOS
- "Should I start on extended-release rather than immediate-release?" ER has half the GI side effects.
- "Can we start at 500mg/day and titrate slowly over 4 weeks?" The slow titration is the difference between tolerating metformin and quitting it.
- "What is my target dose?" 1,500 to 2,000mg/day for PMOS is typical. Higher doses do not produce more benefit.
- "Should we test my B12 annually?" Long-term metformin lowers B12 absorption in 5 to 15 percent of patients.
- "What if I have a stomach bug or am dehydrated?" Pause metformin during illness with significant dehydration to avoid the rare risk of lactic acidosis.
- "Should I take inositol in addition?" Some research suggests adding inositol to metformin produces a slightly larger insulin improvement than either alone. Discuss timing.
Frequently asked questions
Does metformin work for PMOS?
Yes. In a 2022 Cochrane review of 38 trials with 4,366 women, metformin reduced fasting insulin by 30 percent, improved ovulation rates by 1.4 times, and reduced miscarriage rates by around 40 percent in PMOS. The largest benefits are in women with insulin resistance.
What is the metformin dose for PMOS?
The standard adult dose is 1,500 to 2,000mg per day, typically 500mg three times with meals (immediate-release) or 1,000 to 2,000mg once daily with the evening meal (extended-release). Always titrate slowly over 3 to 4 weeks to tolerate the GI side effects.
Does metformin help PMOS weight loss?
Metformin produces a modest 1 to 3 kg weight loss over 6 months, mostly via appetite suppression and improved insulin signaling. It is not a weight-loss drug. Women who combine metformin with a 30/30/40 PMOS diet lose 2 to 3 times more weight than those who take metformin alone.
How long does metformin take to work for PMOS?
Insulin sensitivity changes are detectable in lab work at 4 weeks. Cycle regularity improvements typically appear at 8 to 12 weeks. Significant weight, acne, and hirsutism changes take 3 to 6 months.
Is metformin safe in PMOS pregnancy?
Yes. Metformin is FDA Pregnancy Category B and is considered safe in PMOS pregnancy. The 2020 Lancet meta-analysis of more than 1,500 PCOS pregnancies showed a 40 percent reduction in early miscarriage and 25 percent reduction in gestational diabetes, with no increase in birth defects.
What are the side effects of metformin in PMOS?
Most common: diarrhoea (20-30% on IR, 10-15% on ER), nausea (15-20%), bloating, metallic taste. Long-term: B12 deficiency in 5-15 percent over 5+ years. Rare: lactic acidosis (under 1 in 30,000 patient years). Slow titration and extended-release reduce side effects significantly.
Can I stop metformin for PMOS once symptoms improve?
Stopping metformin typically reverses the insulin sensitivity gains within 4 to 8 weeks unless the underlying lifestyle changes are sustained. Most women stay on metformin long-term. Some women can taper off after 12+ months of consistent lifestyle change with sustained lab improvements, under medical supervision.
What is the difference between metformin and inositol for PMOS?
Both target insulin resistance via different mechanisms. Metformin is a prescription, has stronger evidence at the population level, and is preferred for severe insulin resistance, pre-diabetes, or BMI above 30. Inositol is over-the-counter, has similar effect sizes for mild to moderate insulin resistance, and is preferred when GI side effects are a concern or for fertility prep.
Pair metformin with the right diet
Metformin removes the metabolic barrier. The food does the actual work.
Women on metformin who pair it with a 30/30/40 PMOS diet see 2 to 3 times the weight and symptom changes versus metformin alone. Take the free phenotype quiz to get the PMOS meal plan that matches your phenotype.
What to read next
- Inositol vs metformin for PMOS
- Best supplements for PMOS
- PMOS weight loss diet plan
- PMOS diet: full food list
- PCOS is now PMOS: full renaming explainer
How this article was researched
Sources include the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, the 2022 Cochrane review of metformin in PCOS (38 trials, 4,366 women), the 2020 Lancet meta-analysis of metformin in PCOS pregnancy (1,500+ pregnancies), the 2023 BMJ meta-analysis of fertility interventions in PCOS, and the Diabetes Prevention Program data on metformin in pre-diabetes. PCOS was renamed PMOS on 12 May 2026; metformin recommendations are identical under both names. This article is informational and not medical advice. See our editorial standards.
Community Comments
Add a comment